TC Biopharm executes second LOI to buy CAR-T therapies, shares up [Seeking Alpha]
TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
Company Research
Source: Seeking Alpha
pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors. CAR T-cell therapy modifies a patient's own immune cells to provide a heightened ability to identify and eliminate cancer cells. The target acquisition has developed a number of proprietary approaches to re-engineer CARs to better target solid tumors. The company has generated pre-clinical proof of concept data that demonstrates the therapeutic potential of its lead CAR-T candidate for a range of solid tumors including colorectal, pancreatic, mesothelioma, ovarian and breast cancer. In addition, the target acquisition is also developing a novel, allogeneic CAR-T for the treatment of autoimmune diseases, TC BioPharm ( TCBP ) said. "Management is extremely pleased to announce this second potential acquisition which will provide strong advantages to our current therapeutic platform as well as expand our efforts into autoimmune disea
Show less
Read more
Impact Snapshot
Event Time:
TCBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCBP alerts
High impacting TC BioPharm (Holdings) plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TCBP
News
- TCBP Announces Launch of Compassionate Use Program for TCB008 [Yahoo! Finance]Yahoo! Finance
- TCBP Announces Launch of Compassionate Use Program for TCB008PR Newswire
- TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds [Yahoo! Finance]Yahoo! Finance
- TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross ProceedsPR Newswire
- TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies [Yahoo! Finance]Yahoo! Finance
TCBP
Sec Filings
- 5/20/24 - Form 8-K
- 5/15/24 - Form 10-Q
- 5/8/24 - Form 8-K
- TCBP's page on the SEC website